FNY Partners Fund’s bluebird bio BLUE Stock Holding History

FNY Partners Fund’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-1,976	Closed	-$2.33M	–	622
2017 Q1	$2.33M	Buy	+1,976	New	+$2.02M	0.27%	52

Other funds holding BLUE

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

FNY Partners Fund's BLUE Position: Q2 2017 in Review

FNY Partners Fund sold out of bluebird bio (BLUE) in Q2 2017, closing a stake of 1,976 shares — an estimated $2.33M sold.

FNY Partners Fund first reported a position in BLUE in Q1 2017 and held it in 1 quarter. The position peaked at $2.33M in Q1 2017. 241 funds tracked by Wall St. Rank hold BLUE as of Q2 2017.

FNY Partners Fund reported no remaining bluebird bio position as of Q2 2017 after selling out during the quarter.
FNY Partners Fund sold 1,976 bluebird bio shares in Q2 2017, an estimated $2.33M.
FNY Partners Fund first reported a position in bluebird bio in Q1 2017 and held it in 1 quarter.
FNY Partners Fund's bluebird bio position peaked at $2.33M in Q1 2017.
241 funds tracked by Wall St. Rank held bluebird bio as of Q2 2017.

Based on FNY Partners Fund's 13F filing for Q2 2017, filed 10 Aug 2017.